Reforming the PCPNDT Act: Balancing Gender Justice with Accessible Healthcare

Context

A recent case of delayed breast cancer diagnosis in rural Assam has revived the debate on reforming the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, 1994. While the Act has played a crucial role in preventing sex-selective practices, advances in medical technology have highlighted the need for a regulatory framework that also supports equitable access to diagnostic healthcare.

PCPNDT Act

Background

1. The PCPNDT Act, 1994 was enacted to prohibit pre-conception and prenatal sex selection, a major factor behind the declining child sex ratio in India.
2. It regulates the use of prenatal diagnostic techniques to prevent female foeticide and uphold gender equality.
3. The Act ensures that diagnostic technologies are used solely for legitimate medical purposes.

Key Provisions

1. Mandatory registration of genetic clinics, ultrasound centres and diagnostic laboratories.
2. Complete prohibition on communicating or disclosing the sex of the foetus.
3. Ultrasound equipment can be installed and operated only in registered facilities.
4. Manufacturers must verify purchaser credentials before supplying ultrasound machines.
5. Mandatory maintenance of prescribed records for every diagnostic procedure to ensure transparency and regulatory compliance.

Implementation Outcomes

Positive Outcomes

1. Established a robust legal framework to curb sex-selective abortion.
2. Strengthened regulation and accountability of prenatal diagnostic facilities.
3. Contributed to the gradual improvement in India’s sex ratio at birth.
4. Reinforced constitutional values of gender equality and protection of the girl child.
5. Supported initiatives such as Beti Bachao Beti Padhao by strengthening safeguards against sex-selective practices.

Continuing Concerns

1. Illegal prenatal sex determination continues through clandestine networks despite stringent legal provisions.
2. Persistent son preference indicates that legal enforcement alone cannot eliminate deep-rooted gender bias.
3. Uniform restrictions on ultrasound devices have unintentionally limited their use for legitimate diagnostic healthcare.

Rationale for Reform

1. Limited Access to Diagnostic Healthcare

1. Restrictions on portable ultrasound devices reduce access to early diagnosis of diseases such as breast cancer, particularly in rural and underserved areas.
2. Shortages of specialists and diagnostic infrastructure further delay timely detection and treatment.

2. Outdated Regulatory Framework

1. The Act applies uniform restrictions to all ultrasound devices irrespective of their technical capabilities.
2. High-frequency linear probes, used for imaging superficial organs such as the breast, are incapable of foetal sex determination but remain subject to the same regulatory restrictions as conventional ultrasound machines.

3. Advances in Medical Technology

1. Advances in portable ultrasound and AI-assisted imaging have enabled accurate, community-based diagnostic services with built-in safeguards against misuse.
2. However, the existing legal framework has not kept pace with these technological developments, limiting their wider application in primary healthcare.

Reform Priorities

1. Adopt a risk-based regulatory framework that classifies ultrasound devices according to their potential for misuse.
2. Permit the regulated use of high-frequency linear probes for approved community-based diagnostic services.
3. Incorporate AI-enabled ultrasound systems with appropriate technical safeguards and regulatory oversight.
4. Strengthen compliance through digital governance tools, including geo-tagging of equipment, electronic record management and periodic audits.
5. Build the capacity of ASHA workers, ANMs and other frontline healthcare personnel to use approved portable diagnostic technologies under defined clinical protocols.
6. Continue strict enforcement against illegal sex determination while promoting sustained gender sensitisation and behavioural change through community awareness programmes.

Significance

1. Balances the objectives of gender justice and equitable healthcare access.
2. Promotes early diagnosis and timely treatment, particularly in underserved regions.
3. Strengthens preventive and primary healthcare through improved community-level diagnostic services.
4. Encourages responsible adoption of emerging medical technologies within a robust regulatory framework.
5. Supports evidence-based, technology-responsive and patient-centric healthcare governance.

Conclusion

The PCPNDT Act remains a cornerstone of India’s efforts to eliminate sex-selective practices. However, advances in diagnostic technology and evolving public health needs call for a technology-responsive, risk-based regulatory framework. A balanced regulatory framework that combines technological innovation with robust safeguards can preserve the Act’s core objective while ensuring timely, affordable and equitable access to diagnostic healthcare. Such reforms would align healthcare regulation with technological progress without compromising gender justice.